Global Endobronchial Ultrasound Biopsy Market - 2023-2030

Endobronchial Ultrasound Biopsy The Global Endobronchial Ultrasound Biopsy Market reached US$ 576.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 832.7 million by 2031. The market is expected to exhibit a CAGR of 4.8% during the forecast period (2024-2031). Endobronchial ultrasound biopsy market trends show rising demand for these products, owing to various advantages of this procedure as it is typically performed on an outpatient basis, and patients generally experience minimal discomfort and a short recovery.

Ultrasound imaging enables the physician to guide a biopsy needle through the airway wall and into the targeted area, allowing for the collection of tissue samples for further analysis. The endobronchial ultrasound biopsy market scope includes diagnostics and stage lung cancer, as well as to evaluate other respiratory conditions such as sarcoidosis and lung infections, leading to a surge in endobronchial ultrasound biopsy market share.

New technologies in the endobronchial ultrasound biopsy market such as cryo biopsy, electromagnetic navigational bronchoscopy and ultrathin bronchoscopy have recently been developed to assist in the accurate detection of lung diseases. The endobronchial ultrasonography biopsy, or TBNA, which is utilized as well to sample hilar lymph nodes & can be performed as an outpatient operation with mild sedation, is more intrusive than mediastinoscopy, which takes place inside the mediastinum.

The rising incidence of lung cancer will also drive the endobronchial ultrasound biopsy market’s growth.. For instance, according to the article published in Contemporary Oncology in 2021, an estimated 2 million cases of lung cancer are diagnosed each year and 1.8 million people die from it, making it the primary cause of cancer incidence and mortality worldwide. In both men and women, lung neoplasms are the subsequent most typical cancer diagnosis (after prostate or breast cancer).

Endobronchial Ultrasound Biopsy Market Dynamics

Increasing benefits of endobronchial ultrasound biopsy devices drive the growth of the endobronchial ultrasound biopsy market.

The global endobronchial ultrasound biopsy market is expanding as a result of the increasing benefits of endobronchial ultrasound biopsy devices. Using an endobronchial ultrasonography biopsy, a very accurate diagnostic tool, medical professionals can learn about lung nodules, masses, or lymph nodes. Moreover, it can aid in separating benign from malignant lesions, allowing for a quicker and more efficient course of action.

Endobronchial ultrasonography biopsy has been widely used in clinical settings over the past ten years, according to an article issued by the Journal of Yeungnam Medical Science in 2020. Lung cancer surgical mediastinal staging has been substituted by convex probe endobronchial ultrasound biopsy, which is frequently used to diagnose a variety of central lung abnormalities.

Rising expenditure for research and development proficiencies and regulatory approvals creates lucrative opportunities for manufacturers.

There is a growing market opportunity owing to high expenditure on research and development proficiencies for novel technological advancements. For instance, high-quality endobronchial ultrasound biopsy-TBNA tissue samples are increasingly needed to achieve these goals, which has increased the technical demands and presented new challenges.

The expanding adoption of endobronchial ultrasound biopsy and rising investments by developing and developed nations for medical devices & instruments as a result of the rising prevalence of chronic disorders such as lung cancer will create opportunities for the growth of endobronchialultrasound biopsy market. People are facing issues with various kinds of infections due to which demand for novel innovative technology is increasing for proper diagnosis.

Increasing expenditure on healthcare infrastructure and the development of cutting-edge products such as biopsy forceps or transbronchial aspiration needles are contributing to the growth of the endobronchial ultrasound biopsy market. Hence, producers must invest in R&D to develop new, improved products and meet rising demand.

Endobronchial Ultrasound Biopsy Market Segment Analysis

The global endobronchial ultrasound biopsy market is segmented based on product type, application, end user and region.

Owing to the rising prevalence of lung infections, the transbronchial aspiration needle segment accounted for approximately 38% of the endobronchial ultrasound biopsy market share in 2022.

A transbronchial aspiration needle is inserted through the bronchial wall during the transbronchial needle aspiration (TBNA) process to collect cellular debris. It is used to remove tissue from lesions of the lung or the hilar or mediastinum that are close to the endobronchial tree. In order to guide the surgeon to the intended lesion, a bronchoscopy is used (lung mass or lymph node). Following this, the bronchoscope's working channel is passed through the bronchial wall with the catheter and needle, and the material is aspirated for cytological, histological, or bacteriological investigation.

A major product in the market is eXcelon - Single-Use Transbronchial Aspiration Needle manufactured by Boston Scientific Corporation. It is used for aspiration in carinal, paratracheal, and hilar lesions of the bronchial tree where biopsy forceps cannot obtain a submucosal sample.

Endobronchial Ultrasound Biopsy Market Geographical Share

North America accounted for approximately 39% of the market share in 2022, owing to the strong presence of major players and increasing healthcare infrastructure investment.

Due to the rising need for technological advancements in healthcare, manufacturers in North America have chances of enhancing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for endobronchial ultrasound biopsy for lung cancer diagnosis.

Increasing expenditure on healthcare and rising awareness among people, advancement of technologies for diagnosis or treatment, and increase in pharmaceutical establishment across the region are also contributing to the market growth in this region. Rising novel product launches to support endobronchial ultrasound biopsy usage in people with lung cancer also drives the market growth.

Furthermore, the fast-growing population and rising cancer prevalence has increased demand for technologically advanced endobronchial ultrasound biopsy products. For instance, the American Cancer Society estimated that there were roughly 235,760 new instances of lung cancer in the U.S. annually in 2021 (119,100 in men & 116,660 in women).

Lung cancer claimed the lives of approximately 131,880 people (69,410 in men and 62,470 in women). Individuals are becoming more aware of various kinds of cancer and novel ways for its diagnosis and treatment, leading to the expansion of the market in this region. The above-mentioned factors further highlight North America's dominance on a global scale.

Endobronchial Ultrasound Biopsy Market Companies

The major global players in the endobronchial ultrasound biopsy market include Olympus Corporation, Medtronic, CLINODEVICE, CONMED Corporation, Medi-Globe GmbH, Boston Scientific Corporation, Serpex Medical, Cook Group Incorporated, MICRO-TECH (Nanjing) Co., Ltd., and ACE Medical Devices Pvt. Ltd. among others.

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global endobronchial ultrasound biopsy market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global endobronchial ultrasound biopsy market growth over the forecast period.

Key Developments
• On September 7, 2022, according to Serpex Medical, a U.S.-based medical device producer, Compass Steerable Needles, a steerable biopsy needles that enable precise access to lung lesions in the intrapulmonary area, received 510(k) approval from the U.S. FDA. Serpex Medical wants to use steerable equipment to improve accessibility and accuracy in the diagnosis and treatment of lung cancer.
• On December 8, 2022, the strategic partnership between Olympus, a digital or precision technology manufacturer and EndoClot Plus, Inc. (EPI), a global medical technology business focused on developing and distributing cutting-edge solutions for surgical and medical procedures, expanded to include Europe, the Middle East, and Africa. (EMEA).
• On August 29, 2022, Serpex Medical, a medical device manufacturer based in the U.S., reported that the Recon Steerable Sheath, a steerable endobronchial instrument with articulation at the distal tip to help doctors access hard-to-reach parts of the lung architecture, received 510(k) approval from the U.S. FDA. In order to increase access and precision in the detection and treatment of lung cancer, Serpex Medical aims to make use of steerable equipment.

Why Purchase the Report?
• To visualize the global endobronchial ultrasound biopsy market segmentation based on product type, application, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of endobronchial ultrasound biopsy market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global endobronchial ultrasound biopsy market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies